Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation

Transplantation

Volumn 75, Issue 9, 2003, Pages 1512-1517

  Tzakis, Andreas G ^a   Kato, Tomoaki ^a   Nishida, Seigo ^a   Levi, David M ^a   Tryphonopoulos, Panagiotis ^a   Madariaga, Juan R ^a   De Faria, Werviston ^a   Nery, Jose R ^a   Regev, Arie ^a   Vianna, Rodrigo ^a   Miller, Joshua ^a   Esquenazi, Violet ^a   Weppler, Debbie ^a   Ruiz, Phillip ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYTOMEGALOVIRUS ANTIBODY; DACLIZUMAB; GANCICLOVIR; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; OKT 3; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; ENTERITIS; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INTESTINE TRANSPLANTATION; LOW DRUG DOSE; MYCOSIS; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEPSIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 0037572231     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000060250.50591.39     Document Type: Conference Paper

References (20)

1. Grant D, Wall W, Mimeault R, et al. Successful small-bowel/liver transplantation. Lancet 1990; 335: 181-184.
2. Goulet 0, Revillon Y, Brousse N, et al. Successful small bowel transplantation in an infant. Transplantation 1992; 53: 940-943.
3. Margreiter R, Konigsrainer A, Schmid T, et al. Successful multivisceral transplantation. Transplant Proc 1992; 24: 1226-1227.
4. Starzl TE, Rowe MI, Todo S, et al. Transplantation of multiple abdominal viscera. JAMA 1989; 261: 1449-1457.
5. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222: 270-282.
6. Pinna AD, Weppler D, Nery J, et al. Intestinal transplantation at the University of Miami - five years of experience. Transplant Proc 2000; 32(6): 1226-1227.
7. Kato T, Nishida S, Mittal N, et al. Intestinal transplantation at the University of Miami. Transplant Proc 2002; 34(3): 868.
8. Nishida S, Levi D, Kato T, et al. Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg 2002; 6(2): 233-239.
9. Reyes J, Bueno J, Kocoshis S, et al. Current status of intestinal transplantation in children. J Pediatr Surg 1998; 33: 243-254.
10. Farmer DG, McDiarmid SV, Yersiz H, et al. Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-1032. Arch Surg 2001; 136(9): 1027-1031.
11. Murase N, Ye Q, Nalesnik MA, et al. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000; 70: 1632-1641.
12. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: A decade of experience at a single center. Ann Surg 2001; 234; 404-417.
13. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351(9117): 1701-1702.
14. Calne R, Moffatt SD, Friend PJ, et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999; 68(10): 1613-1616.
15. Kirk AD, Swanson SJ, Mannon RB, et al. Preliminary results from a human tolerance trial using Campath-1H. Am J Transplant [abstract]. 2001; 1(suppl 1): 136.
16. Humar A, Jessurun J, Sharp HL, et al. Hemolytic uremic syndrome in small-bowel transplant recipients: the first two case reports. Transpl Int 1999; 12(5): 387-390.
17. Pinna AD, Weppler D, Nery JR, et al. Induction therapy for clinical intestinal transplantation: comparison of four different regimens. Transplant Proc 2000; 32(6): 1193-1194.
18. Taylor VC, Sims M, Brett S, et al. Antibody selection against CD-52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochem J 1997; 322 (Pt 3): 919-925.
19. Hertenstein B, Wagner B, Bunjes D, et al. Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood 1995; 86(4): 1487-1492.
20. Rawstron AC, Rollinson SJ, Richards S, et al. The PNH phenotype cells that emerge in most patients after Campath-1H therapy are present prior to treatment. Br J Hematol 1999; 107: 148-153.